Diabetic dyslipidemia: a practical guide to therapy
Related Experiment Video
Updated: Jul 4, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
John M Tovar1, Oralia V Bazaldua, Alexandra Loffredo
1Feik School of Pharmacy, University of the Incarnate Word San Antonio, TX USA. jmtovar@uiwtx.edu
Abstract:
Low-density lipoprotein (LDL) should be the primary target of lipid-lowering therapy for patients with diabetes. Because of their robust reduction of LDL, statins are considered the agents of choice for these patients. Triglyceride (TG) and high-density lipoprotein (HDL) levels are also important targets. Combination therapy with fibrates or niacin is common due to concurrent high TG and low HDL levels in these patients. Data supporting an LDL goal of <70 mg/dL for patients with diabetes are limited and contradictory at this time.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures